Daily Archives: March 5, 2015

Zac & Rebekah I It’s in his DNA – Video

Posted: March 5, 2015 at 8:45 pm


Zac Rebekah I It #39;s in his DNA
All rights belongs to TVD/TO and the movie 17 Again + Little Mix. Well, there #39;s no real story. I just watched this movie a couple of days ago and Zac was soooo handsome in this film, I had...

By: Regina Rose Black

Read the original here:
Zac & Rebekah I It's in his DNA - Video

Posted in DNA | Comments Off on Zac & Rebekah I It’s in his DNA – Video

D.C. prosecutors criticize city crime labs handling of some DNA evidence

Posted: at 8:44 pm

D.C. prosecutors have stopped sending DNA evidence to the citys new state-of-the-art crime lab after they said they discovered errors in the way analysts determined whether a sample can be linked to a suspect or a victim.

Prosecutors have hired two outside DNA experts to review 116 cases, including rapes and homicides, and have been notifying defense attorneys.

In one federal case, prosecutors said, the D.C. lab concluded that a defendants DNA could have been on the magazine of a gun seized as evidence. But an expert who reviewed the data said the lab should have interpreted the results to mean that the defendant was not the source of the DNA.

In other cases, prosecutors said, the lab either understated or overestimated the likelihood that a particular persons DNA was left at a crime scene.

Officials at the Department of Forensic Sciences, which is located in a $220million facility that opened in 2012, defend their work and say disagreements among scientists in the field are not uncommon. The dispute has essentially created a standoff between the city-run lab and federal prosecutors in the nations capital.

U.S. Attorney Ronald C. Machen Jr. said that his office has been paying to send evidence for testing at outside labs, and that so far an additional 102 cases have been farmed out. At the same time, independent experts are taking a fresh look at the cases analyzed by the Districts lab.

To date, we have not found any evidence to suggest any wrongful conviction and have not acted to dismiss any cases, Machen said in a statement. However, in an abundance of caution, we are conducting a rigorous review of the analysis done in current and older cases to ensure that criminal defendants are treated fairly.

Max M. Houck, the director of the Department of Forensic Sciences, said that the lab follows the same protocols in place at many city and state labs across the country, and that experts may disagree on how to interpret evidence. The lab has made recent improvements, he said, but he stands by the work done before those changes.

This is an estimate an estimate of probability, said Houck, a former FBI supervisor who worked in the agencys anthropology and trace evidence unit.

The issue is that their experts would do the analysis differently. Differently isnt wrong, Houck said. Its like a financial planner doing a financial assessment of someones net worth in U.S. currency and in Japanese yen. Theyre both correct, just different measurements.

Read more here:
D.C. prosecutors criticize city crime labs handling of some DNA evidence

Posted in DNA | Comments Off on D.C. prosecutors criticize city crime labs handling of some DNA evidence

Engineering the Perfect Baby

Posted: at 8:44 pm

If anyone had devised a way to create a genetically engineered baby, I figured George Church would know about it.

At his labyrinthine laboratory on the Harvard Medical School campus, you can find researchers giving E. Coli a novel genetic code never seen in nature. Around another bend, others are carrying out a plan to use DNA engineering to resurrect the woolly mammoth. His lab, Church likes to say, is the center of a new technological genesisone in which man rebuilds creation to suit himself.

When I visited the lab last June, Church proposed that I speak to a young postdoctoral scientist named Luhan Yang, a Harvard recruit from Beijing whod been a key player in developing a new, powerful technology for editing DNA called CRISPR-Cas9. With Church, Yang had founded a company called eGenesis to engineer the genomes of pigs and cattle, sliding in beneficial genes and editing away bad ones.

As I listened to Yang, I waited for a chance to ask my real questions: Can any of this be done to human beings? Can we improve the human gene pool? The position of much of mainstream science has been that such meddling would be unsafe, irresponsible, and even impossible. But Yang didnt hesitate. Yes, of course, she said. In fact, the laboratory had a project to determine how it could be achieved. She flipped open her laptop to a PowerPoint slide titled Germline Editing Meeting.

Here it was: a technical proposal to alter human heredity.

Germ line is biologists jargon for the egg and sperm, which combine to form an embryo. By editing the DNA of these cells or the embryo itself, it could be possible to eliminate disease genes and to pass those genetic fixes on to future generations. Such a technology could be used to rid families of scourges like cystic fibrosis. It might also be possible to install genes that offer lifelong protection against infection, Alzheimers, and, Yang told me, maybe the effects of aging. These would be history-making medical advances that could be as important to this century as vaccines were to the last.

The fear is that germ line engineering is a path toward a dystopia of super people and designer babies for those who can afford it.

Thats the promise. The fear is that germ line engineering is a path toward a dystopia of super people and designer babies for those who can afford it. Want a child with blue eyes and blond hair? Why not design a highly intelligent group of people who could be tomorrows leaders and scientists?

CRISPR was discovered only three years ago but is already widely used by biologists as a kind of search-and-replace tool to alter DNA, even down to the level of a single letter. Its so precise that its widely expected to turn into a promising new approach for gene therapy treatment in people with devastating illnesses. The idea is that physicians could directly correct a faulty gene, say, in the blood cells of a patient with sickle-cell anemia (see Genome Surgery). But that kind of gene therapy wouldnt affect germ cells, and the changes in the DNA wouldnt get passed to future generations.

In contrast, the genetic changes created by germ line engineering would be passed on, and thats what has always made the idea seem so objectionable. So far, caution and ethical concerns have had the upper hand. A dozen countries, not including the United States, have banned germ line engineering, and scientific societies have unanimously concluded that it would be too risky to do. The European Unions convention on human rights and biomedicine says tampering with the gene pool would be a crime against human dignity and human rights.

Here is the original post:
Engineering the Perfect Baby

Posted in DNA | Comments Off on Engineering the Perfect Baby

Investigating the Human Genome Insights into Human Variation and Disease Susceptibility – Video

Posted: at 8:44 pm


Investigating the Human Genome Insights into Human Variation and Disease Susceptibility
More Information About Book.

By: world book

View post:
Investigating the Human Genome Insights into Human Variation and Disease Susceptibility - Video

Posted in Genome | Comments Off on Investigating the Human Genome Insights into Human Variation and Disease Susceptibility – Video

Melbourne Conversations – Personalised Medicine: Me and My Genome – Video

Posted: at 8:44 pm


Melbourne Conversations - Personalised Medicine: Me and My Genome
Global genomics expert Professor Michael Snyder from Stanford University sequenced his genome and got a shock! Hear his story, get the latest on the work aro...

By: Melb Conversations

Read the original here:
Melbourne Conversations - Personalised Medicine: Me and My Genome - Video

Posted in Genome | Comments Off on Melbourne Conversations – Personalised Medicine: Me and My Genome – Video

Human Genome, Original Music and Original Art by Virgo Rouge – Video

Posted: at 8:44 pm


Human Genome, Original Music and Original Art by Virgo Rouge
Copyright 2015. Virgo Rouge also know as Marissa Elienne http://virgorouge.com All instrumentation by Virgo Rouge. Composition by Virgo Rouge. Visual Artwork...

By: virgorouge

Read the original here:
Human Genome, Original Music and Original Art by Virgo Rouge - Video

Posted in Genome | Comments Off on Human Genome, Original Music and Original Art by Virgo Rouge – Video

Mapping the human genome: The Eric Lander interview – Video

Posted: at 8:44 pm


Mapping the human genome: The Eric Lander interview
Professor Eric Lander is one of the leaders of the Human Genome Project, and a member of US President Barack Obama s scientific advisory panel. In an exclusi...

By: NDTV

Follow this link:
Mapping the human genome: The Eric Lander interview - Video

Posted in Genome | Comments Off on Mapping the human genome: The Eric Lander interview – Video

Fringe Science & Baby Genome Sequencing | SYSK Internet Roundup – Video

Posted: at 8:44 pm


Fringe Science Baby Genome Sequencing | SYSK Internet Roundup
Josh talks about a neat website that offers the best scientific information on fringe topics like the Loch Ness Monster, and you can now have your baby #39;s gen...

By: Stuff You Should Know - HowStuffWorks

More here:
Fringe Science & Baby Genome Sequencing | SYSK Internet Roundup - Video

Posted in Genome | Comments Off on Fringe Science & Baby Genome Sequencing | SYSK Internet Roundup – Video

Genome editing: "completely crazy, completely futuristic" – Video

Posted: at 8:44 pm


Genome editing: "completely crazy, completely futuristic"
Maria Leptin, director of the European Molecular Biology Organization, says the new CRISPR technology, which allows scientists to carry out microsurgery on genes and easily change a DNA sequence ...

By: sciencebusinessltd

See the original post:
Genome editing: "completely crazy, completely futuristic" - Video

Posted in Genome | Comments Off on Genome editing: "completely crazy, completely futuristic" – Video

In vivo CRISPR-Cas9 screen sheds light on cancer metastasis, tumor evolution

Posted: at 8:44 pm

For the first time, CRISPR-Cas9 gene-editing technology has been employed in a whole organism model to systematically target every gene in the genome. A team of scientists at the Broad Institute and MIT's David H. Koch Institute for Integrative Cancer Research have pioneered the use of this technology to "knock out," or turn off, all genes across the genome systematically in an animal model of cancer, revealing genes involved in tumor evolution and metastasis and paving the way for similar studies in other cell types and diseases. The work appears online March 5 in Cell.

"Genome-scale guide RNA libraries are a powerful screening system, and we're excited to start applying it to study gene function in animal models," said co-senior author Feng Zhang, core member of the Broad Institute of MIT and Harvard, investigator at the McGovern Institute for Brain Research at MIT, and assistant professor in the MIT Departments of Brain and Cognitive Sciences and Biological Engineering. "This study represents a first step toward using Cas9 to identify important genes in cancer and other complex diseases in vivo."

"Tumor evolution is an extremely complex set of processes, or hallmarks, controlled by networks of genes," said co-senior author Phillip Sharp, Institute Professor at the Massachusetts Institute of Technology, board member at the Broad Institute, and member of the Koch Institute. "The in vivo application of gene-editing is a powerful platform for functional genomic discovery, offering a novel means to investigate each step in tumor evolution and identify the genes that regulate these hallmarks."

CRISPR-Cas9 gene-editing technology enables scientists to investigate the role of genes and genetic mutations in human biology and disease. The system can remove the function of genes at the DNA level, versus other genetic perturbations like RNA interference that "knock down" genes at the RNA level. Broad Institute scientists previously performed genome-wide screens using CRISPR-Cas9 technology in cellular models, but that approach does not capture the complex processes at play in a whole organism. For example, for cancer to metastasize, malignant cells must leave the primary tumor, enter blood vessels to travel to a distant site in the body, leave the blood vessels, and thrive in a new environment. Zhang and Sharp teamed up to search for genes involved in metastasis by applying CRISPR-Cas9 technology in a whole animal model.

In the new study, cells from a mouse model of non-small cell lung cancer (NSCLC) were treated with the Broad's pooled library of CRISPR guide RNAs targeting every gene in the mouse genome, known as the "mouse genome-scale CRISPR knockout library A" (mGeCKOa), along with the Cas9 DNA-cutting enzyme. The system introduces mutations into specific genes, disrupting their sequence and preventing the production of proteins from those genes. The approach ensured that in each cell, only a single gene was knocked out, and that all genes in the mouse genome were targeted by the heterogeneous population of cells in culture. The researchers then transplanted the cells into a mouse and found that cells treated with the knockout library formed highly metastatic tumors.

Using next-generation sequencing, the scientists were able to identify which genes were knocked out in the primary tumors and in the metastases, indicating that the genes are likely tumor suppressors that normally inhibit tumor growth but, when knocked out, promote it.

The results highlighted some well-known tumor suppressor genes in human cancer, including Pten, Cdkn2a, and Nf2, but included some genes not previously linked to cancer. Unexpectedly, the screen also implicated several microRNAs -- small RNA segments that are functional in the cell.

More experimental work remains to fully explore the genes and microRNAs uncovered in the screen. Metastatic tumors are rarely biopsied in the clinic, making samples for research scarce, but future inclusion of metastases in cancer sequencing studies will yield more insight on hits from this study.

Researchers can take the same in vivo approach described in the Cell paper to examine the effects of gene over-expression, to screen circulating tumor cells or other cell lines, and to explore other cancer phenotypes, such as cancer stem cells, host-environment interactions, and angiogenesis.

"Our work provides a proof-of-principle in vivo knockout screen for identification of genes regulating different routes and steps of tumor evolution," said Sidi Chen, co-first author and a postdoctoral fellow working in the Sharp lab.

More:
In vivo CRISPR-Cas9 screen sheds light on cancer metastasis, tumor evolution

Posted in Genome | Comments Off on In vivo CRISPR-Cas9 screen sheds light on cancer metastasis, tumor evolution